Q/C Technologies, Inc. Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
Q/C Technologies, Inc. (QCLS) reported Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest of -$1.45 million for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-18.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest · last filed 2021-05-18
- Q/C Technologies, Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2021-03-31 was -$1.45M.
- Q/C Technologies, Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2020-12-31 was -$3.11M.
- Q/C Technologies, Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2020-09-30 was -$2.92M.
- Q/C Technologies, Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2020-03-31 was -$3.53M.
- Q/C Technologies, Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2020 was -$12.15M.
- Q/C Technologies, Inc. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2019 was -$3.38M.
| Period end | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2021-03-31 | -$1.45M 10-Q · filed 2021-05-18 | -$4.55M derived: sum of 2 quarters · filed 2021-05-18 | -$7.47M derived: sum of 3 quarters · filed 2021-05-18 | |
| 2020-12-31 | -$3.11M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$6.02M derived: sum of 2 quarters · filed 2021-03-01 | -$12.15M 10-K · filed 2021-03-01 | |
| 2020-09-30 | -$2.92M 10-Q · filed 2020-11-16 | -$9.05M 10-Q · filed 2020-11-16 | ||
| 2020-03-31 | -$3.53M 10-Q · filed 2021-05-18 | -$4.21M derived: sum of 2 quarters · filed 2021-05-18 | -$5.03M derived: sum of 3 quarters · filed 2021-05-18 | |
| 2019-12-31 | -$678.19K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$1.50M derived: sum of 2 quarters · filed 2021-03-01 | -$3.38M 10-K · filed 2021-03-01 | |
| 2019-09-30 | -$820.84K 10-Q · filed 2020-11-16 | -$2.70M 10-Q · filed 2020-11-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |